Press
Global Top 5 AI-Driven Drug Discovery Startup
Top 10 AI and Drug Discovery Company in Europe
Revolutionizing drug research with EU grants
Johnson & Johnson Innovations (JLABS) Resident
Awards
Genome Biologics joins BLUE KNIGHT™
Blue Knight is a joint initiative between Johnson & Johnson Innovation–JLABS and the Biomedical Advanced Research and Development Authority (BARDA) that aims to stimulate and accelerate innovation to improve global health security. Genome Biologics is one of seven companies from across the globe selected to join Blue Knight.
